Viburcol, Engystol, Lymphomyosot — Bioregulatory Approach in Pediatric Practice
Journal Title: Здоров`я дитини - Year 2016, Vol 6, Issue 74
Abstract
One of the most urgent problems in modern pediatrics and neonatology is the need for drugs, which, along with proven efficacy, also will be maximum safe for a growing child’s body. The article presents an overview of publications on clinical studies of combined bioregulatory drugs (CBD) Viburcol, Engystol, Lymphomyosot, Lymphomyosot H by German company Biologische Heilmittel Heel GmbH (hereafter — Heel company), which are widely used in childhood diseases [1–3, 4–9, 11–26]. Scientific and clinical studies show the high efficacy of these drugs, which in some cases is comparable with that of other drugs [4–8]. At the same time, above mentioned CBD have a favorable safety profile and are well tolerated by children [4–9, 11–26].
Authors and Affiliations
S. V. Popovych
Keywords
Related Articles
- EP ID EP182883
- DOI 10.22141/2224-0551.6.74.2016.82131
- Views 82
- Downloads 0
Professional determination problems of modern senior pupils
Background. Today, young people are more focused on getting education as such, without taking into account the profession. The relevance of this study is the identification of the level of professional self-determination...
The problem of effective and safe treatment of acute respiratory infections in children
As the etiological structure of acute respiratory viral infections (ARVI) is polymorphic, the presence of clinical manifestations very rarely allows to establish a connection with a particular pathogen and to prescribe t...
Rational Antitussive Therapy in Children
The article presents the current data about the state of the defense mechanisms of the respiratory tract in children. The questions of antitussive therapy in pediatrics are considered. Recommendations on the use of mucor...
Step-Down Antibiotic Therapy of Community-Acquired Pneumonia in Children with Burdened Allergologic History and Concomitant Allergic Pathology: Focus on Cefpodoxime Proxetil
The use of cefpodoxime proxetil in children with community-acquired pneumonia is effective. In patients with burdened history of allergic events and concomitant allergic pathology, use of cefpodoxime proxetil does not ca...
Status of child population health — the future of the country (part 1)
The article of the team of scientists of pediatricians and organizers of pediatric health care of Ukraine is devoted to the study of the main trends in the health status of children over last 22 years. The results of the...